Cholangiocarcinomas Recruiting Phase 1 Trials for Floxuridine (DB00322)

Also known as: Cholangiocarcinoma / Cholangiocarcinoma NOS / Cholangiocarcinoma of biliary tract

IndicationStatusPhase
DBCOND0051818 (Cholangiocarcinomas)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01525069Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic CholangiocarcinomaTreatment